CAPN14 and eosinophilic esophagitis: Indeed, the 40.0% reduction of CAPN14 promoter activity in the genotype-dependent reporter assays mirrors the effect size of the eQTLs measured in subjects with and without EoE (Kottyan et al. 2014).